Skip to main content
. Author manuscript; available in PMC: 2016 Sep 8.
Published in final edited form as: World J Urol. 2014 Sep 21;33(8):1129–1137. doi: 10.1007/s00345-014-1409-z

Table 1a.

Distribution of demographic and prognostic characteristics among bladder cancer patients who underwent cystectomy, by measured level of preoperative albumin

Preoperative albumin < 3.5
n (%)
Preoperative albumin >= 3.5
n (%)
p-value
Sexa Male 65 (64) 465 (79) <0.01
Female 37 (36) 122 (21)
Raceb African American 13 (14) 24 (4) <0.01
Hispanic 1 (1) 14 (3)
Other 0 (0) 5 (0.9)
White 78 (85) 506 (92)
Resident presence in ORc Yes 65 (71) 390 (74) 0.57
No 26 (29) 135 (26)
Level of resident surgeon in ORd No resident 22 (27) 92 (21) 0.02
PGY 1 3 (4) 5 (1)
PGY 2 3 (4) 10 (2)
PGY 3 5 (6) 27 (6)
PGY 4 13 (16) 55 (12)
PGY 5 20 (24) 88 (20)
PGY 6+ 17 (20) 171 (38)
Year of operatione 2005, 2006, 2007, 2008, or 2009 34 (33) 151 (26) 0.11
2010, 2011, or 2012 68 (67) 438 (74)
Diabetes mellitus treated with oral agents or insuline Diabetic treated with insulin 7 (7) 27 (5) 0.60
Diabetic treated with oral agents 13 (13) 84 (14)
Not diabetic 82 (80) 478 (81)
Smoker in past yeare Yes 32 (31) 145 (25) 0.15
No 70 (69) 444 (75)
More than 2 alcoholic drinks in 2 weeks prior to admissione Yes 5 (5) 26 (4) 0.83
No 97 (95) 563 (96)
Functional statuse At least partially dependent 9 (9) 7 (1) <0.01
Independent 93 (91) 582 (99)
One or more pulmonary comorbidities (dyspnea, ventilator dependence, COPD, and/or pneumonia)e Yes 23 (23) 91 (15) 0.07
No 79 (77) 498 (85)
One or more cardiac comorbidities (CHF, MI, angina, PCI, and/or previous cardiac surgery)e Yes 16 (16) 98 (17) 0.81
No 86 (84) 491 (83)
Hypertension requiring medicatione Yes 61 (60) 346 (59) 0.84
No 41 (40) 243 (41)
Preoperative acute renal failuree Yes 6 (6) 4 (0.7) <0.01
No 96 (94) 585 (99)
Preoperative dialysise Yes 0 (0) 2 (0.3) 0.56
No 102 (100) 587 (100)
One or more vascular comorbidities (revascularization and/or rest pain)e Yes 1 (1) 8 (1) 0.76
No 101 (99) 581 (99)
One or more neurological comorbidities (coma, hemiplegia, TIA, CVA with neurological deficit, CVA without neurological deficit, tumor involving CNS, paraplegia, and/or quadriplegia)e Yes 8 (8) 29 (5) 0.23
No 94 (92) 560 (95)
Steroid use for chronic conditione Yes 2 (2) 20 (3) 0.45
No 100 (98) 569 (97)
Greater than 10% loss in body weight in the last 6 monthse Yes 5 (5) 21 (4) 0.51
No 97 (95) 568 (96)
Bleeding disordere Yes 5 (5) 22 (4) 0.57
No 97 (95) 567 (96)
Radiotherapy for malignancy in last 90 dayse Yes 3 (3) 1 (0.2) <0.01
No 99 (97) 588 (100)
Prior operation within 30 daysf Yes 9 (9) 37 (6) 0.33
No 92 (91) 550 (94)
ASA classificatione ASA 1 and 2 13 (13) 139 (24) 0.01
ASA 3, 4 and 5 89 (87) 450 (76)
Transfused more than 4 units pRBCs in 72 hours prior to surgerye Yes 8 (8) 8 (1) <0.01
No 94 (92) 581 (99)
Preoperative albumin < 3.0
(median [IQR])
Preoperative albumin >= 3.0
(median [IQR])
Age (years)g 70 (61–78) 68 (61–76) 0.31
Operative time (min) 312 (247–426) 329 (258–423) 0.32
BMIh 26.0 (23.0–30.2) 27.9 (24.5–31.6) <0.01
a

Missing=524

b

Missing=572

c

Missing=597

d

Missing=682

e

Missing=522

f

Missing=525

g

Missing 4 from Preoperative albumin >= 3.5 category

h

Missing 2 from Preoperative albumin < 3.5 category and 4 from Preoperative albumin >= 3.5 category